All News #Library
Biotech
Oblique Therapeutics Advances NaV 1.8 Project To Next Stage
22 Oct 2024 //
PR NEWSWIRE
Oblique Therapeutics Partners With Eli Lilly On AbiProt® Technology
22 Aug 2024 //
PR NEWSWIRE

Market Place
Sourcing Support